Boston Scientific

MARLBOROUGH, Mass., July 29, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.003 billion during the second quarter

Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device New stroke risk reduction technology designed

Boston Scientific Announces Conference Call Discussing Second Quarter 2020 Financial Results MARLBOROUGH, Mass., June 30, 2020 /PRNewswire/ — Boston Scientific Corporation

Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx™ Insertable Cardiac Monitor System First ICM device with remote programming paired

Boston Scientific Receives Medicare Transitional Pass-Through Payment for the EXALT™ Model D Single-Use Duodenoscope MARLBOROUGH, Mass., June 8, 2020 /PRNewswire/

Tool provides electrophysiologists with first-ever local measurement and visualization of tissue response to radiofrequency ablation MARLBOROUGH, Mass., June 1, 2020

Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock MARLBOROUGH, Mass., May 27,

MARLBOROUGH, Mass., May 26, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Jefferies 2020 Virtual

Boston Scientific Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock MARLBOROUGH, Mass., May 21, 2020 /PRNewswire/ — Boston

Boston Scientific Announces Offerings of Common Stock and Mandatory Convertible Preferred Stock MARLBOROUGH, Mass., May 20, 2020 /PRNewswire/ — Boston

MARLBOROUGH, Mass., May 18, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) completed a public offering of $1.7 billion aggregate principal

MARLBOROUGH, Mass., May 14, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of

PINNACLE FLX Study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020

Late-Breaking Clinical Trial Data Underscore Safety And Efficacy Of Boston Scientific S-ICD System Outcomes presented at HRS 2020 SCIENCE demonstrate

MARLBOROUGH, Mass., May 6, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will participate in three upcoming virtual investor conferences. On

MARLBOROUGH, Mass., April 29, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.543 billion during the first quarter of

New Renewable Energy Agreements To Reduce Boston Scientific Carbon Footprint By Half New energy deal puts Boston Scientific on pace

Boston Scientific Announces 2020 Annual Meeting of Stockholders Will Be Conducted in Virtual Format MARLBOROUGH, Mass., April 10, 2020 /PRNewswire/

MARLBOROUGH, Mass., April 2, 2020 /PRNewswire/ — The COVID-19 pandemic has brought unprecedented challenges upon the global community and the many

MARLBOROUGH, Mass., Feb 18, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will participate in three upcoming investor conferences. On February

MARLBOROUGH, Mass., Feb. 5, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.905 billion during the fourth quarter

Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year 2019 MARLBOROUGH, Mass., Jan. 14, 2020 /PRNewswire/

Boston Scientific Announces January Conference Schedule and Conference Call Discussing Fourth Quarter 2019 Results Conference schedule includes 38th Annual J.P.

MARLBOROUGH, Mass., Dec. 13, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA)

Boston Scientific to Participate in Evercore ISI and Piper Jaffray Healthcare Conferences MARLBOROUGH, Mass., Nov. 21, 2019 /PRNewswire/ — Boston